BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5486460)

  • 1. Effects of some adrenergic neuron blockers, related quaternary ammonium compounds and guanidine derivatives on degenerating adrenergic nerves in the conscious rat.
    Lundberg D
    Acta Physiol Scand; 1970 Nov; 80(3):323-44. PubMed ID: 5486460
    [No Abstract]   [Full Text] [Related]  

  • 2. Bretylium and the degeneration contraction of the sympathetically innervated periorbital smooth muscle in the rat.
    Lundberg D
    Acta Physiol Scand; 1970 Jul; 79(3):411-22. PubMed ID: 5450416
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenergic neuron blockers and transmitter release after sympathetic denervation studied in the conscious rat.
    Lundberg D
    Acta Physiol Scand; 1969 Mar; 75(3):415-26. PubMed ID: 4307123
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral noradrenaline and adrenergic transmission in the rat.
    Spriggs TL
    Br J Pharmacol Chemother; 1966 Jan; 26(1):271-81. PubMed ID: 5919511
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of adrenergic block by noradrenaline low temperature and sodium deficiency.
    Manchandia MR; Gulati OD
    Indian J Physiol Pharmacol; 1974; 18(2):86-92. PubMed ID: 4153407
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct studies on the disappearance of the transmitter and changes in the uptake-storage mechanisms of degenerating adrenergic nerves.
    Malmfors T; Sachs C
    Acta Physiol Scand; 1965 Jul; 64(3):211-23. PubMed ID: 5855019
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for the participation of a cholinergic receptor in adrenergic transmission.
    Lederer E; Rand MJ; Wilson J
    Arch Int Pharmacodyn Ther; 1970 May; 185(1):105-20. PubMed ID: 4319312
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the mechanism of the adrenergic blocking action of bretylium and guanethidine].
    Haeusler G; Haefely W; Huerlimann A
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):241-3. PubMed ID: 4242393
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
    Jonsson G; Malmfors T; Sachs C
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenergic neurone blocking activity of some new guanidine derivatives.
    Kadzielawa K; Gumulka W
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):287-96. PubMed ID: 4294770
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection against traumatic shock by guanethidine, bretylium and betaTM 10.
    LUM BK; CALVERT DN
    J Pharmacol Exp Ther; 1962 Oct; 138():74-7. PubMed ID: 13931638
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of tetramethylammonium iodide and trimethylamine hydrochloride on postganglionic sympathetic nerve fibers].
    Avakian OM; Kaltrikian AA
    Biull Eksp Biol Med; 1968 May; 65(5):71-4. PubMed ID: 5757811
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification of sympathetic nerve stimulation frequency-response relationship in rabbit ileum by guanethidine, bretylium and tetracaine.
    Kihara M; Kubo T; Misu Y
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):180-5. PubMed ID: 6667066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic bretylium treatment on the sympathetic neuron and the smooth musculature of the rat.
    Murdoch SD; Evans BK; Heath JW; Hill CE; Burnstock G
    Eur J Pharmacol; 1977 Jun; 43(3):225-35. PubMed ID: 872877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation of ganglionic transmission by some adrenergic neurone blocking drugs.
    Farmer JB; Rand MJ; Wilson J
    Int J Neuropharmacol; 1966 May; 5(3):241-6. PubMed ID: 4380550
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between adrenergic neurone blocking activity and local anaesthetic activity in a series of guanidine derivatives.
    Rand MJ; Wilson J
    Eur J Pharmacol; 1967 May; 1(3):200-9. PubMed ID: 6069945
    [No Abstract]   [Full Text] [Related]  

  • 17. Degeneration of adrenergic nerves produced by 6-hydroxydopamine.
    Sachs C
    Br J Pharmacol; 1968 Sep; 34(1):224P. PubMed ID: 5692085
    [No Abstract]   [Full Text] [Related]  

  • 18. On the mechanism of the adrenergic nerve blocking action of bretylium.
    Haeusler G; Haefely W; Huerlimann A
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(3):260-77. PubMed ID: 4243221
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.
    Thoenen H; Huerlimann A; Haefely W
    J Pharmacol Exp Ther; 1966 Feb; 151(2):189-95. PubMed ID: 5932597
    [No Abstract]   [Full Text] [Related]  

  • 20. Blocking action of some quaternary derivatives of 2-(2,6-xylyloxy)ethylamine on adrenergic nerves.
    Clark ER; Hughes IE
    Br J Pharmacol Chemother; 1966 Oct; 28(1):105-27. PubMed ID: 6008445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.